About Careers MedBlog Contact us

Lung Cell Transplant Could Offer Protection Against Lung Damage

by Iswarya on August 21, 2019 at 1:01 PM
Font : A-A+

Lung Cell Transplant Could Offer Protection Against Lung Damage

Some flu cases are so severe as they cause lasting injury to the lungs, but a novel study points to a new strategy where lung cell transplant may one day offer protection against this damage, reports a new study. The findings of the study are published in the journal Regenerative Medicine.

The scientists found that transplanting a certain type of lung cell from healthy mice to those that had been injured by infection with influenza could improve healing. The transplant--achieved by taking specialized lung cells called alveolar type-two (AT2) cells from the healthy animals and then allowing the sick animals to breathe in the cells simply--led to improved blood-oxygen levels.


"We took this really simple approach," says Andrew Vaughan, senior author on the paper and an assistant professor in Penn's School of Veterinary Medicine, "and asked if we could supplement back these AT2 cells into injured mice, can we make them better, can we improve lung regeneration?"

"Imagine if this were in humans," adds Aaron Weiner, lead author on the study and a graduate student in Vaughan's lab. "If there were a bad flu season coming up, it could be routine to say, can you take some of my AT2 cells, grow them up for me, and if I get sick, you can just put them back in to help me recover. That biobank idea is what we're imagining."

Earlier work by Vaughan and colleagues had focused on the negative outcomes that can arise following injury to the lung, such as a serious infection. In the current investigation, they attempted to recreate a healthy recovery in mice that had been infected with the flu. The healing process involves AT2 cells, which normally produce surfactant, a substance that lowers surface tension in the lung's alveoli to ensure proper function. But AT2 cells can also take on a stem cell-like activity, able to both self-renew and to give rise to alveolar type 1 (AT1) cells, which are responsible for gas exchange in the lungs.

Weiner, Vaughan, and colleagues decided to try to take advantage of this ability of AT2 cells to see if they could aid healing.

They first developed a method to grow AT2 cells taken from healthy mice in culture, and then transplant those cells into mice 11 days after being infected with influenza. Nearly two weeks after the transplant, the researchers found that the cells had grown in the recipient's lungs but either remained as AT2 cells or developed markers associated with unhealthy regeneration.

Trying a different tack, the team took roughly a million AT2 cells isolated from healthy mice and directly transplanted them to sick ones. This approach had more success.

"Only a few thousand of the cells stick around in the lungs," says Weiner. "But the important thing we show is that two weeks after we transplant these cells, we see these huge engraftments where the AT2 cells have proliferated a ton and differentiated into the oxygen-exchanging AT1 cells."

"If you weren't looking for the fluorescent tag that we put on the transplanted cells, you wouldn't even be able to distinguish them from the normal tissue," Vaughan says.

The transplant also had a physiological benefit, the researchers demonstrated. Mice that got the transplant of primary AT2 cells had significantly higher blood-oxygen saturation than mice that got a "mock" transplant of saline solution, a sign of a stronger recovery.

"These engraftments are very long-lived," Weiner notes. "One hundred days after the transplant, we find engraftments that are really robust and maintain the cell lineage and have presumably helped in some way for the mice to get better."

As a final test of their methods, the team transplanted AT2 cells into mice that had experience other types of lung injury, including acid inhalation, chemotherapy exposure, and bacterial pneumonia.

"To our surprise, it worked really well in two of the three injury models we tested," Vaughan says. They saw robust engraftment after both acid inhalation and chemotherapy, though not for bacterial pneumonia.

Source: Eurekalert


Recommended Reading

Latest Respiratory Disease News

Could a Severe Heatwave Lead to Asthma?
The global climate crisis is stimulating heat waves to become more frequent causing distress to people with asthma, say experts.
Why Is Vitamin D3 Essential for Allergic Asthma?
A new study reveals vitamin D3 supplements have encouraging effects for asthma patients. Vitamin D has a positive effect on immune response.
Why Are First Nations Population at Risk of Severe Flu?
Hospitalization and mortality rates are on the higher side in First Nations communities than comparable populations.
Ending Tobacco Use: A Blueprint Towards Eradicating Tuberculosis
To end TB by 2030, we need to decrease tuberculosis risk factors and reduce NCDs, among other vital steps to strengthen health systems.
18,000 Influenza Deaths Reported in the United States
Influenza, commonly called the flu, is an acute, contagious, respiratory tract infection, which is caused by one of the influenza viruses
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Lung Cell Transplant Could Offer Protection Against Lung Damage Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests